Pancreatic Cancer
Pancreatic cancer is the fifth leading cause of cancer death in
Western societies, with a five year survival rate of less than 10%. The
treatment and survival of patients with pancreatic cancer has not
changed for over thirty years because there has been little research
into the molecular and cell biology associated with it. Our projects
focus on understanding the role of retinoic acid signalling pathways in
pancreatic cancer and defining new diagnostic and treatment strategies
that may extend the successful use of retinoids seen in leukemia and
skin cancer to pancreatic cancer.
Staff
| Senior Research Officer Chris Scarlett |
Amanda Mawson |
Mark Pinese |
Vivienna Ong |
Johana Susanto |
Amber Johns |
Emily Colvin |
PhD Student David Chang |
| Data Clerks Rhys Merrett Yun Si Lim Natalie Purcell Michelle Thomas Bronwyn Thorp |
News
2005 Young Investigator of the Year
01 Jul 2006
Dr Andrew Biankin, Head of Pancreatic Cancer Research, is the recipient of the highly acclaimed 2005 Cure Cancer National Young Researcher of the Year award.
